|
1
|
Takahashi S: Molecular functions of
metallothionein and its role in hematological malignancies. J
Hematol Oncol. 5:412012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hamer DH: Metallothionein. Annu Rev
Biochem. 55:913–951. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cherian MG, Jayasurya A and Bay BH:
Metallothioneins in human tumors and potential roles in
carcinogenesis. Mutat Res. 533:201–209. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Datta J, Majumder S, Kutay H, et al:
Metallothionein expression is suppressed in primary human
hepatocellular carcinomas and is mediated through inactivation of
CCAAT/enhancer binding protein alpha by phosphatidylinositol
3-kinase signaling cascade. Cancer Res. 67:2736–2746. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yan DW, Fan JW, Yu ZH, et al:
Downregulation of metallothionein 1F, a putative oncosuppressor, by
loss of heterozygosity in colon cancer tissue. Biochim Biophys
Acta. 1822:918–926. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wei H, Desouki MM, Lin S, Xiao D, Franklin
RB and Feng P: Differential expression of metallothioneins (MTs) 1,
2, and 3 in response to zinc treatment in human prostate normal and
malignant cells and tissues. Mol Cancer. 7:72008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Theocharis SE, Margeli AP, Klijanienko JT
and Kouraklis GP: Metallothionein expression in human neoplasia.
Histopathology. 45:103–118. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ofner D, Maier H, Riedmann B, et al:
Immunohistochemical metallothionein expression in colorectal
adenocarcinoma: correlation with tumour stage and patient survival.
Virchows Arch. 425:491–497. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang B, Satoh M, Nishimura N, et al:
Metallothionein deficiency promotes mouse skin carcinogenesis
induced by 7,12-dimethylbenz[a]anthracene. Cancer Res.
58:4044–4046. 1998.PubMed/NCBI
|
|
10
|
Poulsen CB, Borup R, Borregaard N, Nielsen
FC, Møller MB and Ralfkiaer E: Prognostic significance of
metallothionein in B-cell lymphomas. Blood. 108:3514–3519. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bay BH, Jin R, Huang J and Tan PH:
Metallothionein as a prognostic biomarker in breast cancer. Exp
Biol Med (Maywood). 231:1516–1521. 2006.
|
|
12
|
Shukla VK, Aryya NC, Pitale A, et al:
Metallothionein expression in carcinoma of the gallbladder.
Histopathology. 33:154–157. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weinlich G, Eisendle K, Hassler E, Baltaci
M, Fritsch PO and Zelger B: Metallothionein-overexpression as a
highly significant prognostic factor in melanoma: a prospective
study on 1270 patients. Br J Cancer. 94:835–841. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
You HJ, Lee KJ and Jeong HG:
Overexpression of human metallothionein-III prevents hydrogen
peroxide-induced oxidative stress in human fibroblasts. FEBS Lett.
521:175–179. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Surowiak P, Materna V, Maciejczyk A, et
al: Nuclear metallothionein expression correlates with cisplatin
resistance of ovarian cancer cells and poor clinical outcome.
Virchows Arch. 450:279–285. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Imoto A, Okada M, Okazaki T, Kitasato H,
Harigae H and Takahashi S: Metallothionein-1 isoforms and vimentin
are direct PU.1 downstream target genes in leukemia cells. J Biol
Chem. 285:10300–10309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suzuki S, Nakano H and Takahashi S:
Epigenetic regulation of the metallothionein-1A promoter by PU.1
during differentiation of THP-1 cells. Biochem Biophys Res Commun.
433:349–353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ghoshal K and Jacob ST: Regulation of
metallothionein gene expression. Prog Nucleic Acid Res Mol Biol.
66:357–384. 2001.
|
|
19
|
Laukens D, Waeytens A, De Bleser P,
Cuvelier C and De Vos M: Human metallothionein expression under
normal and pathological conditions: mechanisms of gene regulation
based on in silico promoter analysis. Crit Rev Eukaryot Gene Expr.
19:301–317. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Haq F, Mahoney M and Koropatnick J:
Signaling events for metallothionein induction. Mutat Res.
533:211–226. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Radtke F, Heuchel R, Georgiev O, et al:
Cloned transcription factor MTF-1 activates the mouse
metallothionein I promoter. EMBO J. 12:1355–1362. 1993.PubMed/NCBI
|
|
22
|
Palmiter RD: Regulation of metallothionein
genes by heavy metals appears to be mediated by a zinc-sensitive
inhibitor that interacts with a constitutively active transcription
factor, MTF-1. Proc Natl Acad Sci USA. 91:1219–1223. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Andrews GK, Lee DK, Ravindra R, et al: The
transcription factors MTF-1 and USF1 cooperate to regulate mouse
metallothionein-I expression in response to the essential metal
zinc in visceral endoderm cells during early development. EMBO J.
20:1114–1122. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
LaRochelle O, Labbe S, Harrisson JF, et
al: Nuclear factor-1 and metal transcription factor-1
synergistically activate the mouse metallothionein-1 gene in
response to metal ions. J Biol Chem. 283:8190–8201. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Westin G and Schaffner W: A
zinc-responsive factor interacts with a metal-regulated enhancer
element (MRE) of the mouse metallothionein-I gene. EMBO J.
7:3763–3770. 1988.PubMed/NCBI
|
|
26
|
Dalton T, Palmiter RD and Andrews GK:
Transcriptional induction of the mouse metallothionein-I gene in
hydrogen peroxide-treated Hepa cells involves a composite major
late transcription factor/antioxidant response element and metal
response promoter elements. Nucleic Acids Res. 22:5016–5023. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Murphy BJ, Andrews GK, Bittel D, et al:
Activation of metallothionein gene expression by hypoxia involves
metal response elements and metal transcription factor-1. Cancer
Res. 59:1315–1322. 1999.PubMed/NCBI
|
|
28
|
Günther V, Lindert U and Schaffner W: The
taste of heavy metals: gene regulation by MTF-1. Biochim Biophys
Acta. 1823:1416–1425. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Paonessa G, Gounari F, Frank R and Cortese
R: Purification of a NF1-like DNA-binding protein from rat liver
and cloning of the corresponding cDNA. EMBO J. 7:3115–3123.
1988.PubMed/NCBI
|
|
30
|
Rupp RA, Kruse U, Multhaup G, Göbel U,
Beyreuther K and Sippel AE: Chicken NFI/TGGCA proteins are encoded
by at least three independent genes: NFI-A, NFI-B and NFI-C with
homologues in mammalian genomes. Nucleic Acids Res. 18:2607–2616.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Meisterernst M, Rogge L, Foeckler R,
Karaghiosoff M and Winnacker EL: Structural and functional
organization of a porcine gene coding for nuclear factor I.
Biochemistry. 28:8191–8200. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Majumder S, Ghoshal K, Gronostajski RM and
Jacob ST: Downregulation of constitutive and heavy metal-induced
metallothionein-I expression by nuclear factor I. Gene Expr.
9:203–215. 2001.PubMed/NCBI
|
|
33
|
Jacob ST, Majumder S and Ghoshal K:
Suppression of metallothionein-I/II expression and its probable
molecular mechanisms. Environ Health Perspect. 110(Suppl 5):
827–830. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tang CM, Westling J and Seto E: trans
repression of the human metallothionein IIA gene promoter by PZ120,
a novel 120-kilo-dalton zinc finger protein. Mol Cell Biol.
19:680–689. 1999.
|
|
35
|
Datta J, Majumder S, Bai S, et al:
Physical and functional interaction of DNA methyltransferase 3A
with Mbd3 and Brg1 in mouse lymphosarcoma cells. Cancer Res.
65:10891–10900. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yin H, Smith M and Glass J: Stable
expression of C/EBPalpha in prostate cancer cells down-regulates
metallothionein and increases zinc-induced toxicity. Prostate.
62:209–216. 2005. View Article : Google Scholar
|
|
37
|
Ghoshal K, Li Z and Jacob ST:
Overexpression of the large subunit of the protein Ku suppresses
metallothionein-I induction by heavy metals. Proc Natl Acad Sci
USA. 95:10390–10395. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Majumder S, Kutay H, Datta J, Summers D,
Jacob ST and Ghoshal K: Epigenetic regulation of metallothionein-i
gene expression: differential regulation of methylated and
unmethylated promoters by DNA methyltransferases and methyl CpG
binding proteins. J Cell Biochem. 97:1300–1316. 2006. View Article : Google Scholar
|
|
39
|
Koschmieder S, Halmos B, Levantini E and
Tenen DG: Dysregulation of the C/EBPalpha differentiation pathway
in human cancer. J Clin Oncol. 27:619–628. 2009. View Article : Google Scholar :
|
|
40
|
Majumder S, Ghoshal K, Li Z and Jacob ST:
Hypermethylation of metallothionein-I promoter and suppression of
its induction in cell lines overexpressing the large subunit of Ku
protein. J Biol Chem. 274:28584–28589. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mao J, Yu H, Wang C, et al:
Metallothionein MT1M is a tumor suppressor of human hepatocellular
carcinomas. Carcinogenesis. 33:2568–2577. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Compere SJ and Palmiter RD: DNA
methylation controls the inducibility of the mouse
metallothionein-I gene lymphoid cells. Cell. 25:233–240. 1981.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Arriaga JM, Levy EM, Bravo AI, et al:
Metallothionein expression in colorectal cancer: relevance of
different isoforms for tumor progression and patient survival. Hum
Pathol. 43:197–208. 2012. View Article : Google Scholar
|
|
44
|
Faller WJ, Rafferty M, Hegarty S, et al:
Metallothionein 1E is methylated in malignant melanoma and
increases sensitivity to cisplatin-induced apoptosis. Melanoma Res.
20:392–400. 2010.PubMed/NCBI
|
|
45
|
Peng D, Hu TL, Jiang A, et al:
Location-specific epigenetic regulation of the metallothionein 3
gene in esophageal adenocarcinomas. PLoS One. 6:e220092011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rosenbauer F, Wagner K, Kutok JL, et al:
Acute myeloid leukemia induced by graded reduction of a
lineage-specific transcription factor, PU.1. Nat Genet. 36:624–630,
Epub 2004 May 2016. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pettersson M, Sundström C, Nilsson K and
Larsson LG: The hematopoietic transcription factor PU.1 is
downregulated in human multiple myeloma cell lines. Blood.
86:2747–2753. 1995.PubMed/NCBI
|
|
48
|
Inoue K and Takano H: Metallothionein as a
negative regulator of pulmonary inflammation. Curr Pharm
Biotechnol. 14:414–419. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mocchegiani E, Costarelli L, Basso A,
Giacconi R, Piacenza F and Malavolta M: Metallothioneins, ageing
and cellular senescence: a future therapeutic target. Curr Pharm
Des. 19:1753–1764. 2013.
|
|
50
|
Hirako N, Nakano H and Takahashi S: A PU.1
suppressive target gene, metallothionein 1G, inhibits retinoic
acid-induced NB4 cell differentiation. PLoS One. 9:e1032822014.
View Article : Google Scholar : PubMed/NCBI
|
